Sen-Jam Pharmaceutical is a biotechnology and pharmaceutical startup that is revolutionizing the treatment of inflammation and challenging the traditional practices of the pharma industry. Founded in 2017, the company's groundbreaking approach is evident from its slogan: "We’re changing the way the world treats inflammation and the way the pharma industry treats humanity." Sen-Jam has attracted attention and investment from powerful players in the startup ecosystem. In November 2018, StartUp Health participated in a Seed Round investment, demonstrating their confidence in Sen-Jam's vision and potential.
The company's innovative product, with a multi-indication patent and pending FDA approval, targets the prevention of pain and flu-like symptoms for conditions that are currently overlooked by the FDA OTC Drug Monograph. Sen-Jam's global team of scientists is committed to creating a world with more resilient individuals, free from side-effects and filled with remarkable living. To become part of this impactful revolution, individuals and investors can explore the opportunity to invest in Sen-Jam Pharmaceutical through https:\/\/wefunder.com\/senjam.
